- Corporate Officers - G
- Grossman D Keith
Insider Trading History of Grossman D Keith
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Grossman D Keith since 2006.
This trader's CIK number is 1218702.
At the time of last reporting, Grossman D Keith was the Director of Outset Medical, Inc.. (stock ticker symbol OM).
Also see all insider trading activities at Outset Medical, Inc..
Note that in the past
GROSSMAN D KEITH also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Intuitive Surgical Inc (ISRG) by Grossman D Keith
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | ISRG | 0 | $0 | 9,250 | $3,271,750 | 9,250 | $2,017,907 |
2009 | ISRG | 0 | $0 | 7,500 | $2,011,154 | 7,500 | $949,200 |
2007 | ISRG | 0 | $0 | 15,500 | $3,062,666 | 15,500 | $772,499 |
2006 | ISRG | 0 | $0 | 5,000 | $495,840 | 5,000 | $82,550 |
Yearly summary of insider trading at Thoratec Corp (THOR) by Grossman D Keith
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | THOR | 0 | $0 | 10,000 | $376,230 | 0 | $0 |
2010 | THOR | 0 | $0 | 25,000 | $1,046,170 | 0 | $0 |
2009 | THOR | 0 | $0 | 15,000 | $413,313 | 0 | $0 |
2008 | THOR | 0 | $0 | 19,000 | $481,065 | 0 | $0 |
2006 | THOR | 0 | $0 | 425,812 | $8,170,642 | 358,000 | $4,802,169 |
Yearly summary of insider trading at Outset Medical, Inc. (OM) by Grossman D Keith
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | OM | 0 | $0 | 0 | $0 | 187,500 | $0 |
2024 | OM | 0 | $0 | 38,117 | $143,777 | 69,303 | $76,926 |
2021 | OM | 0 | $0 | 19,440 | $1,046,569 | 13,022 | $14,452 |
Yearly summary of insider trading at Nevro Corp (NVRO) by Grossman D Keith
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | NVRO | 3,200 | $203,488 | 0 | $0 | 0 | $0 |
2021 | NVRO | 7,000 | $735,490 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Grossman D Keith:
1. Intuitive Surgical Inc (ISRG)
2. Thoratec Corp (THOR)
3. Outset Medical, Inc. (OM)
4. Nevro Corp (NVRO)
Table 1. Insider trading of Intuitive Surgical Inc (ISRG) by Grossman D Keith
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-04-23 | ISRG | Option Ex | 4,250 | 135.39 | 575,407 |
2010-04-23 | ISRG | Sale | 4,250 | 367.26 | 1,560,850 |
2010-02-19 | ISRG | Option Ex | 5,000 | 288.50 | 1,442,500 |
2010-02-19 | ISRG | Sale | 5,000 | 342.18 | 1,710,900 |
2009-12-10 | ISRG | Sale | 2,500 | 292.10 | 730,260 |
2009-12-10 | ISRG | Option Ex | 2,500 | 133.31 | 333,275 |
2009-11-06 | ISRG | Option Ex | 5,000 | 123.19 | 615,925 |
2009-11-06 | ISRG | Sale | 5,000 | 256.18 | 1,280,894 |
2007-12-11 | ISRG | Option Ex | 2,500 | 113.06 | 282,650 |
2007-12-11 | ISRG | Sale | 2,500 | 350.17 | 875,422 |
2007-07-31 | ISRG | Sale | 1,258 | 213.28 | 268,312 |
2007-07-31 | ISRG | Option Ex | 1,258 | 47.09 | 59,239 |
2007-07-31 | ISRG | Sale | 1,884 | 213.28 | 401,827 |
2007-07-31 | ISRG | Option Ex | 1,884 | 47.09 | 88,717 |
2007-07-31 | ISRG | Sale | 1,858 | 213.09 | 395,913 |
2007-07-31 | ISRG | Option Ex | 1,858 | 47.09 | 87,493 |
2007-06-04 | ISRG | Option Ex | 8,000 | 31.80 | 254,400 |
2007-06-04 | ISRG | Sale | 8,000 | 140.15 | 1,121,192 |
2006-11-07 | ISRG | Sale | 5,000 | 99.17 | 495,840 |
2006-11-07 | ISRG | Option Ex | 5,000 | 16.51 | 82,550 |
Table 2. Insider trading of Thoratec Corp (THOR) by Grossman D Keith
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-12-06 | THOR | Sale | 10,000 | 37.62 | 376,230 |
2010-05-13 | THOR | Sale | 5,000 | 43.23 | 216,170 |
2010-05-03 | THOR | Sale | 20,000 | 41.50 | 830,000 |
2009-08-07 | THOR | Sale | 400 | 28.00 | 11,200 |
2009-08-11 | THOR | Sale | 14,600 | 27.54 | 402,113 |
2008-09-03 | THOR | Sale | 5,000 | 27.50 | 137,500 |
2008-08-28 | THOR | Sale | 5,000 | 26.48 | 132,425 |
2008-08-05 | THOR | Sale | 9,000 | 23.46 | 211,140 |
2006-02-06 | THOR | Sale | 271,000 | 19.06 | 5,165,260 |
2006-02-02 | THOR | Option Ex | 57,000 | 10.00 | 570,171 |
2006-02-03 | THOR | Option Ex | 30,000 | 12.45 | 373,500 |
2006-02-02 | THOR | Sale | 124,812 | 19.51 | 2,435,082 |
2006-02-03 | THOR | Sale | 30,000 | 19.01 | 570,300 |
2006-02-06 | THOR | Option Ex | 271,000 | 14.24 | 3,858,498 |
Table 3. Insider trading of Outset Medical, Inc. (OM) by Grossman D Keith
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-03-10 | OM | Option Ex | 187,500 | .00 | 0 |
2024-06-03 | OM | Option Ex | 69,303 | 1.11 | 76,926 |
2024-06-03 | OM | Sale | 38,117 | 3.77 | 143,777 |
2021-12-01 | OM | Sale | 1,296 | 47.92 | 62,104 |
2021-11-01 | OM | Sale | 3,888 | 54.66 | 212,498 |
2021-09-17 | OM | Option Ex | 5,184 | 1.11 | 5,754 |
2021-10-01 | OM | Sale | 1,296 | 49.69 | 64,398 |
2021-10-01 | OM | Option Ex | 62 | 1.11 | 68 |
2021-09-17 | OM | Sale | 5,184 | 55.00 | 285,120 |
2021-09-01 | OM | Option Ex | 1,296 | 1.11 | 1,438 |
2021-09-01 | OM | Sale | 1,296 | 49.17 | 63,721 |
2021-07-01 | OM | Sale | 1,296 | 49.23 | 63,804 |
2021-07-01 | OM | Option Ex | 1,296 | 1.11 | 1,438 |
2021-05-03 | OM | Option Ex | 2,592 | 1.11 | 2,877 |
2021-05-03 | OM | Sale | 2,592 | 58.72 | 152,204 |
2021-04-01 | OM | Option Ex | 2,592 | 1.11 | 2,877 |
2021-04-01 | OM | Sale | 2,592 | 55.06 | 142,720 |
Table 4. Insider trading of Nevro Corp (NVRO) by Grossman D Keith
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-08 | NVRO | Buy | 3,200 | 63.59 | 203,488 |
2021-08-13 | NVRO | Buy | 7,000 | 105.07 | 735,490 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Grossman D Keith
(Director of Outset Medical, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.